Literature DB >> 20837469

Transmembrane BAX inhibitor motif containing (TMBIM) family proteins perturbs a trans-Golgi network enzyme, Gb3 synthase, and reduces Gb3 biosynthesis.

Toshiyuki Yamaji1, Kiyotaka Nishikawa, Kentaro Hanada.   

Abstract

Globotriaosylceramide (Gb3) is a well known receptor for Shiga toxin (Stx), produced by enterohemorrhagic Escherichia coli and Shigella dysenteriae. The expression of Gb3 also affects several diseases, including cancer metastasis and Fabry disease, which prompted us to look for factors involved in its metabolism. In the present study, we isolated two cDNAs that conferred resistance to Stx-induced cell death in HeLa cells by expression cloning: ganglioside GM3 synthase and the COOH terminus region of glutamate receptor, ionotropic, N-methyl-D-asparate-associated protein 1 (GRINA), a member of the transmembrane BAX inhibitor motif containing (TMBIM) family. Overexpression of the truncated form, named GRINA-C, and some members of the full-length TMBIM family, including FAS inhibitory molecule 2 (FAIM2), reduced Gb3, and lactosylceramide was accumulated instead. The change of glycolipid composition was restored by overexpression of Gb3 synthase, suggesting that the synthase is affected by GRINA-C and FAIM2. Interestingly, the mRNA level of Gb3 synthase was unchanged. Rather, localization of the synthase as well as TGN46, a trans-Golgi network marker, was perturbed to form punctate structures, and degradation of the synthase in lysosomes was enhanced. Furthermore, GRINA-C was associated with Gb3 synthase. These observations may demonstrate a new type of posttranscriptional regulation of glycosyltransferases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20837469      PMCID: PMC2975175          DOI: 10.1074/jbc.M110.154229

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  56 in total

1.  Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants.

Authors:  J E Samuel; L P Perera; S Ward; A D O'Brien; V Ginsburg; H C Krivan
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

2.  Synthesis of non-hydroxy-galactosylceramides and galactosyldiglycerides by hydroxy-ceramide galactosyltransferase.

Authors:  P van der Bijl; G J Strous; M Lopes-Cardozo; J Thomas-Oates; G van Meer
Journal:  Biochem J       Date:  1996-07-15       Impact factor: 3.857

3.  Cloning of cDNA for the glutamate-binding subunit of an NMDA receptor complex.

Authors:  K N Kumar; N Tilakaratne; P S Johnson; A E Allen; E K Michaelis
Journal:  Nature       Date:  1991-11-07       Impact factor: 49.962

4.  Prediction of outcome of advanced cervical cancer to thermoradiotherapy according to expression profiles of 35 genes selected by cDNA microarray analysis.

Authors:  Yoko Harima; Akira Togashi; Kenichi Horikoshi; Masahiro Imamura; Mitsuharu Sougawa; Satoshi Sawada; Tatsuhiko Tsunoda; Yusuke Nakamura; Toyomasa Katagiri
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-09-01       Impact factor: 7.038

5.  Role of carbohydrates in protein secretion and turnover: effects of tunicamycin on the major cell surface glycoprotein of chick embryo fibroblasts.

Authors:  K Olden; R M Pratt; K M Yamada
Journal:  Cell       Date:  1978-03       Impact factor: 41.582

6.  Intracellular retention and degradation of human mutant variant of a alpha 1-antitrypsin in stably transfected Chinese hamster ovary cell lines.

Authors:  E Ciccarelli; M A Alonso; D Cresteil; A Bollen; P Jacobs; F Alvarez
Journal:  Eur J Biochem       Date:  1993-04-01

7.  Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro.

Authors:  C A Lingwood; H Law; S Richardson; M Petric; J L Brunton; S De Grandis; M Karmali
Journal:  J Biol Chem       Date:  1987-06-25       Impact factor: 5.157

8.  Bax inhibitor-1, a mammalian apoptosis suppressor identified by functional screening in yeast.

Authors:  Q Xu; J C Reed
Journal:  Mol Cell       Date:  1998-02       Impact factor: 17.970

9.  The bacterial colicin active against tumor cells in vitro and in vivo is verotoxin 1.

Authors:  H Farkas-Himsley; R Hill; B Rosen; S Arab; C A Lingwood
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-18       Impact factor: 11.205

10.  Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide.

Authors:  M Jacewicz; H Clausen; E Nudelman; A Donohue-Rolfe; G T Keusch
Journal:  J Exp Med       Date:  1986-06-01       Impact factor: 14.307

View more
  28 in total

1.  A Conserved Structural Motif Mediates Retrograde Trafficking of Shiga Toxin Types 1 and 2.

Authors:  Andrey S Selyunin; Somshuvra Mukhopadhyay
Journal:  Traffic       Date:  2015-11-02       Impact factor: 6.215

2.  Glycosylphosphatidylinositol anchors regulate glycosphingolipid levels.

Authors:  Ursula Loizides-Mangold; Fabrice P A David; Victor J Nesatyy; Taroh Kinoshita; Howard Riezman
Journal:  J Lipid Res       Date:  2012-05-24       Impact factor: 5.922

Review 3.  TMBIM-mediated Ca2+ homeostasis and cell death.

Authors:  Qun Liu
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2017-01-05       Impact factor: 4.739

4.  TMBIM3/GRINA is a novel unfolded protein response (UPR) target gene that controls apoptosis through the modulation of ER calcium homeostasis.

Authors:  D Rojas-Rivera; R Armisén; A Colombo; G Martínez; A L Eguiguren; A Díaz; S Kiviluoto; D Rodríguez; M Patron; R Rizzuto; G Bultynck; M L Concha; J Sierralta; A Stutzin; C Hetz
Journal:  Cell Death Differ       Date:  2012-01-13       Impact factor: 15.828

Review 5.  Golgi glycosylation.

Authors:  Pamela Stanley
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-04-01       Impact factor: 10.005

6.  Quantitative transcriptomic profiling of branching in a glycosphingolipid biosynthetic pathway.

Authors:  Hiromu Takematsu; Harumi Yamamoto; Yuko Naito-Matsui; Reiko Fujinawa; Kouji Tanaka; Yasushi Okuno; Yoshimasa Tanaka; Mamoru Kyogashima; Reiji Kannagi; Yasunori Kozutsumi
Journal:  J Biol Chem       Date:  2011-06-10       Impact factor: 5.157

7.  Blood group P1 antigen-bearing glycoproteins are functional but less efficient receptors of Shiga toxin than conventional glycolipid-based receptors.

Authors:  Kanta Morimoto; Noriko Suzuki; Isei Tanida; Soichiro Kakuta; Yoko Furuta; Yasuo Uchiyama; Kentaro Hanada; Yusuke Suzuki; Toshiyuki Yamaji
Journal:  J Biol Chem       Date:  2020-05-14       Impact factor: 5.157

8.  Targeting cellular squalene synthase, an enzyme essential for cholesterol biosynthesis, is a potential antiviral strategy against hepatitis C virus.

Authors:  Kyoko Saito; Yoshitaka Shirasago; Tetsuro Suzuki; Hideki Aizaki; Kentaro Hanada; Takaji Wakita; Masahiro Nishijima; Masayoshi Fukasawa
Journal:  J Virol       Date:  2014-12-03       Impact factor: 5.103

9.  Differential expression profiles of glycosphingolipids in human breast cancer stem cells vs. cancer non-stem cells.

Authors:  Yuh-Jin Liang; Yao Ding; Steven B Levery; Marlin Lobaton; Kazuko Handa; Sen-itiroh Hakomori
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-11       Impact factor: 11.205

10.  Lack of iGb3 and Isoglobo-Series Glycosphingolipids in Pig Organs Used for Xenotransplantation: Implications for Natural Killer T-Cell Biology.

Authors:  Fatima Tahiri; Yunsen Li; David Hawke; Luciane Ganiko; Igor Almeida; Steven Levery; Dapeng Zhou
Journal:  J Carbohydr Chem       Date:  2013-01-11       Impact factor: 1.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.